Roche Holding AG (LTS:0QOK)
CHF 248.4 1.25 (0.51%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.78 PB Ratio: 6.84 GF Score: 84/100

Roche Holding AG at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 01:10PM GMT
Release Date Price: CHF348.33 (-0.73%)
Michael Leuchten
UBS Investment Bank, Research Division - Co-Head of Pharmaceuticals Research of Equity Research

So good morning, good afternoon, everybody. My name is Michael Leuchten, pharma -- I'm one of the pharma analysts at UBS in London. Welcome to this fireside set with Roche. It's my pleasure to have CEO, Severin Schwan, with us on the line as well as Karl Mahler, Head of IR.

Severin's going to make some opening remarks, and then we're going to jump into Q&A. There is an ability for you to submit questions if you want to that I can see on the screen. If we have some time, I'm more than happy to circle back to them. But without further ado, Severin, over to you.

Severin Schwan
Roche Holding AG - CEO & Executive Director

Thank you, Michael. I'll keep it very short on my end so that we can quickly go into your questions.

You have seen Q1 results with plus 7%, and that's really very much the result of the new product launches, which continue to overcompensate for the biosimilar erosion. Obviously, we have also been very much

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot